Sulfonylureas Use Is Not Associated With Increased Infarct Size in Patients With Type 2 Diabetes and ST-Segment Elevation Myocardial Infarction

Sulfonylureas Use Is Not Associated With Increased Infarct Size in Patients With Type 2 Diabetes and ST-Segment Elevation Myocardial Infarction

Aims: This retrospective study assessed the association between sulfonylureas use and infarct size in patients with type 2 diabetes (T2DM) and ST-segment elevation myocardial infarction (STEMI) by myocardial enzymology indexes and cardiac magnetic resonance (CMR) imaging.Methods: Patients presenting...

Full description

Bibliographic Details
Main Authors: Fang-Hong Shi, Hao Li, Ling-Cong Kong, Long Shen, Yi-Hong Jiang, Zhi-Chun Gu, Heng Ge
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-05-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
ST-segment elevation myocardial infarction
type 2 diabetes mellitus
sulfonylureas
infarct size
cardiac magnetic resonance
microvascular obstruction
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2021.658059/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2021.658059/full

Similar Items